Indegene Lifesystems Pvt Ltd., a scientific partner to global pharmaceutical and life sciences companies, today highlighted the benefits its pharmaceutical clients are reaping through comprehensive and multichannel patient support and adherence programs. Non-adherence to prescribed medication is rampant and is a cause of worry especially in patients with chronic diseases. This results in patients not achieving the desired health outcomes and increased healthcare costs. Indegene offers an integrated solution that facilitates better health outcomes through personalized reminders, educational resources, specialized contact centers, disease algorithms, and multichannel support through a proprietary platform called “Optimax.” Traditionally, patient intervention programs relied on educational brochures and trained counselors to influence patient adherence. However, many such programs fail to deliver the objective as these programs are not scalable and physician participation is minimal. Most patient support programs go unnoticed due to poor visibility among patients and influencers. Indegene has leveraged its extensive scientific insights to develop a unique framework. Using the right blend of channels and services is critical to ensure alignment to the consumers, prescribers, and the influencer’s ecosystem around the common objective of adherence and retention. Mr. Manish Gupta, CEO, Indegene Lifesystems, said, “Today, nonadherence to pharmacotherapy has been reported to range from 13% to 93%, with an average rate of 40%, globally.” He further added, “Nonadherence has implications in terms of a patient’s health outcomes and increased cost to the patient as well as the healthcare system. Realignment and improvement of patient adherence and compliance management strategies are known to drive better health outcomes and ensure that the challenge does not escalate further.” The pharmaceutical industry is slowly responding to the challenges by reaching out to consumers in a meaningful manner. As patient health outcomes gain center stage, it is imperative that the industry focuses on the promotion of better health outcomes by improving the dismal adherence rates. About Indegene Lifesystems: Indegene is a scientific partner to life sciences companies that enhances the commercialization and marketing success of their products across the product life cycle. Through the depth of scientific expertise, scale of operations, hybrid offshore delivery model, global footprint, and a suite of proprietary platforms and services, Indegene partners with life sciences companies across the globe. Indegene’s range of solutions and services include Medical Affairs and Medical Information Management, Medical Education, Sales Training, Competitive Intelligence and Information Research, Data Analytics, Patient Value Services, and Alternate Sales Channels. Indegene provides significant cost benefits in traditional services as well as IP and significant capabilities in New Commercial Models. For more information, please visit www.indegene.com.